tiprankstipranks
Iradimed Corp (IRMD)
NASDAQ:IRMD
US Market

Iradimed (IRMD) Income Statement

Compare
152 Followers

Iradimed Income Statement

Last quarter (Q3 2024), Iradimed's total revenue was $18.33M, an increase of 11.04% from the same quarter last year. In Q3, Iradimed's net income was $5.05M. See Iradimed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 65.56M$ 53.30M$ 41.81M$ 31.72M$ 38.52M
Gross Profit
$ 50.16M$ 41.28M$ 32.05M$ 23.57M$ 29.70M
Operating Expenses
$ 30.12M$ 25.65M$ 22.23M$ 24.33M$ 21.05M
Depreciation and Amortization
$ 765.18K$ 670.67K$ 634.01K$ 603.60K$ 591.18K
EBITDA
$ 20.80M$ 16.30M$ 11.22M$ 582.73K$ 9.89M
Operating Income
$ 20.04M$ 15.63M$ 9.82M$ -756.09K$ 8.65M
Other Income/Expenses
$ 1.70M$ 553.10K$ 18.61K$ 139.21K$ 395.91K
Pretax Income
$ 21.74M$ 16.18M$ 9.84M$ -616.88K$ 9.04M
Net Income
$ 17.19M$ 12.83M$ 9.33M$ 1.37M$ 9.63M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 1.36$ 1.02$ 0.76$ 0.11$ 0.85
Diluted EPS
$ 1.35$ 1.02$ 0.74$ 0.11$ 0.78
Weighted Average Shares Outstanding
12.60M 12.56M 12.35M 12.12M 11.28M
Weighted Average Shares Outstanding (Diluted)
12.72M 12.64M 12.59M 12.44M 12.28M
Currency in USD

Iradimed Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis